Skip to main content
Log in

Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

A high affinity folate receptor is expressed in some human cancers,including choroid plexus tumors and ependymomas, and has been suggested as a target for therapeutics. In this report, the expression of folate receptors in an SV40 large T antigen transgenicmouse (SV11) was investigated. SV11 mice develop choroid plexus tumors, a property that may be related to the observation that SV40 has been isolated from human choroid plexus tumors and ependymomas. We report that SV11 choroid plexus tumors containa high affinity folate receptor (D of 1 nM), detectable by 125I-folate autoradiography and immunohistochemistry.Western blot analysis indicated an apparent molecular weight of 38 kDa.RT-PCR revealed the presence of transcripts for bothalpha and beta isoforms of the folate receptor. Brain parenchyma hasundetectable folate receptor, but normal choroid plexus has substantiallevels (as does human choroid plexus). The folate receptors of the tumorare accessible from the bloodstream whereasthose of the normal choroid plexus are not. Thus SV11 transgenic mice should be useful for evaluating therapeutic targeting of high affinity folate receptors, both for efficacy of specific agents andpossible side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allen J, Wisoff J, Helson L, Pearce J, Arenson E: Choroid plexus carcinoma–responses to chemotherapy alone in newly diagnosed young children. J Neurooncol 12: 69–74, 1992

    Google Scholar 

  2. Dohrmann GJ, Farwell JR, Flannery JT: Ependymomas and ependymoblastomas in children. J Neurosurg 45: 273–283, 1976

    Google Scholar 

  3. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL: DNA sequences similar to those of simian virus-40 in ependymomas and choroid plexus tumors of childhood. N E J Med 326: 988–993, 1992

    Google Scholar 

  4. Lednicky JA, Garcea RL, Bersagel DJ, Butel JS: Natural simian virus strains are present in human choroid plexus and ependymoma tumors. Virology 212: 710–717, 1995

    Google Scholar 

  5. Brinster RL, Chen HY, Messing A, Van Dyke TA, Levine AJ, Palmiter R: Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37: 367–379, 1984

    Google Scholar 

  6. Feigenbaum L, Hinrichs SH, Jay G: JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virology 66: 1176–1182, 1992

    Google Scholar 

  7. Van Dyke TA, Finlay C, Miller D, Marks J, Lozano G, Levine AJ: Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J Virology 61: 2029–2032, 1987

    Google Scholar 

  8. Chen J, Tobin GJ, Pipas JM, Van Dyke T: T antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 7: 1167–1175, 1992

    Google Scholar 

  9. Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI, Zurawski VR Jr: Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 51: 6125–6132, 1991

    Google Scholar 

  10. Miotti S, Canevari S, Menard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tabliabue E, Colnaghi MI: Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 39: 297–303, 1987

    Google Scholar 

  11. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr, Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396–3401, 1992

    Google Scholar 

  12. Weitman SD, Frazier KM, Kamen BA: The folate receptor in central nervous system malignancies of childhood. J Neurooncol 21: 107–112, 1994

    Google Scholar 

  13. Brigle KE, Westin EH, Houghton MT, Goldman ID: Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. J Biol Chem 266: 17243–17249, 1991

    Google Scholar 

  14. Lacey SW, Sanders JM, Rothberg KG, Anderson RG, Kamen BA: Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J Clin Invest 84: 715–720, 1989

    Google Scholar 

  15. Ratnam M, Marquardt H, Duhring JL, Freisheim JH: Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 28: 8249–8254, 1989

    Google Scholar 

  16. Sadasivan E, Rothenberg SP: The complete amino acid sequence of a human folate binding protein from KB cells determined from the cDNA [published erratum appears in J Biol Chem 1990 Jan 25: 265(3): 1821]. J Biol Chem 264: 5806–5811, 1989

    Google Scholar 

  17. Shen F, Ross JF, Wang X, Ratnam M: Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33: 1209–1215, 1994

    Google Scholar 

  18. Elwood PC: Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J Biol Chem 264: 14893–14901, 1989

    Google Scholar 

  19. Goldman ID: The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann NY Acad Sci 186: 400–422, 1971

    Google Scholar 

  20. Westerhof GR, Jansen G, van Emmerik N, Kathmann I, Rijksen G, Jackman AL, Schornagel JH: Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier-and receptor-mediated transport systems. Cancer Res 51: 5507–5513, 1991

    Google Scholar 

  21. Dixon KH, Mulligan T, Chung KN, Elwood PC, Cowan KH: Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells. J Biol Chem 267: 24140–24147, 1992

    Google Scholar 

  22. Chung KN, Saikawa Y, Paik TH, Dixon KH, Mulligan T, Cowan KH, Elwood PC: Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to anti-folates. J Clin Invest 91: 1289–1294, 1993

    Google Scholar 

  23. Buist MR, Kenemans P, Denhollander W, Vermorken JB, Molthoff CJM, Burger CW, Helmerhorst TJM, Baak JPA, Roos JC: Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody mov18 igg and f(ab’) (2) fragments in ovarian carcinoma patients. Cancer Res 53: 5413–5418, 1993

    Google Scholar 

  24. Ross JF, Chaudhuri PK, Ratnam M: Differential regulation of folate receptor isoforms in normal and malignant tissues in vivoand in established cell lines–physiologic and clinical implications. Cancer 73: 2432–2443, 1994

    Google Scholar 

  25. Pizzorno G, Cashmore AR, Moroson BA, Cross AD, Smith AK, Marling-Cason M, Kamen BA, Beardsley GP: 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRFCEM and MA104 cell lines. J Biol Chem 268: 1017–1023, 1993

    Google Scholar 

  26. Lee RJ, Low PS: Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233: 134–144, 1995

    Google Scholar 

  27. Leamon CP, Pastan I, Low PS: Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cells–contribution of translocation domain. J Biol Chem 268: 24847–24854, 1993

    Google Scholar 

  28. Canevari S, Miotti S, Bottero F, Valota O, Colnaghi MI: Ovarian carcinoma therapy with monoclonal antibodies. Hybridoma 12: 501–507, 1993

    Google Scholar 

  29. Bolhuis RLH, Lamers CHJ, Goey HS, Eggermont AMM, Trimbos JB, Stoter G, Lanzavecchia A, Di Re E, Miotti S, Raspagliesi F, Rivoltini L, Colnaghi MI: Adoptive immunotherapy of ovarium carcinoma with Bs-MAb targeted lymphocytes. A multicenter study. Int J Cancer 7: 78–81, 1992

    Google Scholar 

  30. Kranz DM, Patrick TA, Brigle KE, Spinella MJ, Roy EJ: Conjugates of folate and anti-T cell receptor antibodies specifically target folate receptor positive tumor cells for lysis. Proc Natl Acad Sci USA 92: 9057–9061, 1995

    Google Scholar 

  31. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989

    Google Scholar 

  32. Dhillon HS, Donaldson D, Dempsey RJ, Prasad MR: Regional levels of free fatty acids and Evans blue extravasation after experimental brain injury. J Neurotrauma 11: 405–415, 1994

    Google Scholar 

  33. Brigle KE, Spinella MJ, Westin EH, Goldman ID: Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem Pharmacol 47: 337–345, 1994

    Google Scholar 

  34. Leamon CP, Low PS: Selective targeting of malignant cells with cytotoxin-folate conjugates. J Drug Target 2: 101–112, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patrick, T.A., Kranz, D.M., Dyke, T.A.v. et al. Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J Neurooncol 32, 111–123 (1997). https://doi.org/10.1023/A:1005713115147

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005713115147

Navigation